Published in Surv Ophthalmol on June 16, 2016
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature (2008) 8.42
Mutations in GNA11 in uveal melanoma. N Engl J Med (2010) 7.52
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group. J Clin Oncol (2008) 3.58
The interferons. Mechanisms of action and clinical applications. JAMA (1991) 2.68
Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol (1997) 2.66
Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol (2003) 2.56
American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Ophthal Plast Reconstr Surg (2012) 2.17
Conjunctival Primary Acquired Melanosis: Is It Time for a New Terminology? Am J Ophthalmol (2015) 1.94
Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology (2010) 1.86
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Clin Cancer Res (2013) 1.84
The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. Am J Ophthalmol (2005) 1.84
Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol (2000) 1.83
Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology (1989) 1.81
Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology (1988) 1.69
Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma. Br J Ophthalmol (2008) 1.61
Conjunctival melanoma. Surv Ophthalmol (1998) 1.61
Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology (2004) 1.59
Gastric metastases from conjunctival melanoma. Melanoma Res (2007) 1.53
Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol (1994) 1.52
Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization. J Cutan Pathol (2010) 1.52
Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Res (2004) 1.51
Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci (2005) 1.47
Scleral melt after cryotherapy for conjunctival melanoma. Ophthalmology (1993) 1.46
Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol (1993) 1.46
Mortality after uveal and conjunctival melanoma: which tumour is more deadly? Acta Ophthalmol (2008) 1.44
Ocular melanoma: an overview of the current status. Int J Clin Exp Pathol (2013) 1.43
Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol (2004) 1.43
Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents. Graefes Arch Clin Exp Ophthalmol (2012) 1.42
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Arch Ophthalmol (2000) 1.40
Assessment of anterior segment tumors with ultrasound biomicroscopy versus anterior segment optical coherence tomography in 200 cases. Ophthalmology (2011) 1.39
Naming the Precursors of Conjunctival Melanoma. Am J Ophthalmol (2015) 1.39
Malignant melanoma of the conjunctiva. Hum Pathol (1985) 1.36
Conjunctival melanoma. Arch Ophthalmol (1980) 1.30
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Graefes Arch Clin Exp Ophthalmol (2005) 1.28
Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol (2002) 1.25
Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology (2001) 1.25
Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture. Ophthalmology (2007) 1.22
Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol (2002) 1.22
Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Clin Experiment Ophthalmol (2006) 1.21
Ocular melanoma: relatively rare but requiring respect. Clin Dermatol (2008) 1.21
Conjunctival malignant melanoma in Sweden 1969-91. Acta Ophthalmol (Copenh) (1992) 1.17
Ranpirnase--an antitumour ribonuclease: its potential role in malignant mesothelioma. Expert Opin Biol Ther (2006) 1.16
Pigmented conjunctival squamous cell carcinoma simulating a conjunctival melanoma. Am J Ophthalmol (2001) 1.13
Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol (1993) 1.12
Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography. Ophthalmology (2013) 1.12
Corneally displaced malignant conjunctival melanomas. Ophthalmology (2002) 1.12
Topical treatment options for conjunctival neoplasms. Clin Ophthalmol (2008) 1.11
Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol (1998) 1.11
Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol (1996) 1.08
Impression cytology of conjunctival melanosis and melanoma. Br J Ophthalmol (1992) 1.08
Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol (1996) 1.07
Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento. Br J Ophthalmol (1992) 1.06
Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sci (2011) 1.06
Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Experiment Ophthalmol (2008) 1.06
Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg (2007) 1.05
Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol (2007) 1.04
Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol (1980) 1.02
Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma. Br J Ophthalmol (2010) 1.02
Imaging microscopic pigment chemistry in conjunctival melanocytic lesions using pump-probe laser microscopy. Invest Ophthalmol Vis Sci (2013) 1.01
BRAF mutations in conjunctival melanoma. Invest Ophthalmol Vis Sci (2004) 1.00
Surgical management of circumscribed conjunctival melanomas. Ophthal Plast Reconstr Surg (1998) 0.99
Conjunctival melanoma: bladder and upper urinary tract metastases. J Clin Oncol (2010) 0.99
"Finger-tip" cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia. Br J Ophthalmol (2005) 0.98
Conjunctival amelanotic malignant melanoma arising in primary acquired melanosis sine pigmento. Ophthalmology (1998) 0.97
Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci (2002) 0.97
Interferon alpha for the treatment of melanocytic conjunctival lesions. Graefes Arch Clin Exp Ophthalmol (2009) 0.97
Malignant melanoma of the conjunctiva. Cancer Control (2004) 0.97
Tear cytology in conjunctival melanoma. Am J Ophthalmol (1991) 0.97
Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology (2011) 0.96
BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res (2004) 0.95
An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond) (2008) 0.95
Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion. Clin Experiment Ophthalmol (2009) 0.95
Clinical characterization of primary acquired melanosis. Invest Ophthalmol Vis Sci (1995) 0.94
Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology (2009) 0.93
Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas. Am J Ophthalmol (2008) 0.92
T1799A BRAF mutations in conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci (2005) 0.92
Pathology of ocular melanomas. Br Med Bull (1995) 0.92
Nasal and orbital recurrence of conjunctival melanoma 21 years after exenteration. Br J Ophthalmol (1992) 0.92
Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. Ophthalmology (2011) 0.92
Amelanotic malignant melanoma of the conjunctiva with local metastasis to the eyelid. Can J Ophthalmol (1990) 0.92
Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol (2005) 0.91
Radiotherapy for ocular tumours. Eye (Lond) (2012) 0.90
Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. Am J Ophthalmol (2003) 0.90
Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg (2001) 0.90
Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg (2004) 0.89
Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res (2007) 0.88
Mitomycin: clinical applications in ophthalmic practice. Drugs (2006) 0.88
Seborrheic keratosis of conjunctiva simulating a malignant melanoma: an immunocytochemical study with impression cytology. Ophthalmology (1999) 0.87
Assessment of chromosome 3 copy number in ocular melanoma using fluorescence in situ hybridization. Cancer Genet Cytogenet (1997) 0.87
Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. Int J Surg Pathol (2009) 0.87
Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR). Br J Pharmacol (2011) 0.87
Conjunctival melanoma: local-regional control rates, and impact of high-risk histopathologic features. J Cutan Pathol (2010) 0.86
High-Resolution Optical Coherence Tomography as an Adjunctive Tool in the Diagnosis of Corneal and Conjunctival Pathology. Ocul Surf (2015) 0.86
Recurrent malignant melanoma of the corneal stroma: a case of 'black cornea'. Br J Ophthalmol (1992) 0.85
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Oncogene (2006) 0.85
Topical mitomycin C in the treatment of pigmented conjunctival lesions. Cornea (2003) 0.85
Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. Arch Ophthalmol (2002) 0.85
Infected epithelial inclusion cyst simulating conjunctival melanoma. Ophthal Plast Reconstr Surg (2013) 0.85
Combined local excision and brachytherapy with ruthenium-106 in the treatment of epibulbar malignancies. Ophthalmologica (1993) 0.85
Uveal prolapse following cataract extraction simulating melanoma. Ophthalmic Surg Lasers Imaging (2008) 0.84